[Bacteriological evaluation of clindamycin-2-phosphate (author's transl)]
Related Experiment Videos
Abstract:
Clindamycin-2-phosphate, a newly developed injectable antibiotic, was bacteriologically evaluated in comparison with the parent compound, clindamycin. Clindamycin-2-phosphate has a rather weak antibacterial activity. However, it is metabolized into clindamycin in vivo. And this parent compound shows strong activity against both gram-positive bacteria and gram-negative cocci. In vitro studies demonstrated that clindamycin-2-phosphate and clindamycin are affected by the pH of the medium used--the antibacterial activity becomes stronger as the medium is made more alkaline--while they are little affected by the size of the inoculum. In mice with experimental infections, clindamycin-2-phosphate showed about the same therapeutical effect as clindamycin in contrast with the former's inferior in vitro activity as compared with the latter.
Insights
Clindamycin-2-phosphate, an injectable antibiotic, shows weak in vitro activity but is converted to active clindamycin in vivo. Both forms demonstrate enhanced efficacy in alkaline conditions against gram-positive bacteria and gram-negative cocci.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Clindamycin is a potent antibiotic effective against gram-positive and gram-negative cocci.
- Clindamycin-2-phosphate is a novel injectable formulation of clindamycin.
Purpose of the Study:
- To compare the in vitro and in vivo antibacterial activity of clindamycin-2-phosphate with clindamycin.
- To evaluate the influence of pH and inoculum size on the efficacy of both compounds.
Main Methods:
- Bacteriological evaluation of clindamycin-2-phosphate and clindamycin.
- In vitro susceptibility testing against various bacteria.
- In vivo therapeutic efficacy studies in mice with experimental infections.
- Assessment of pH and inoculum size effects on antibacterial activity.
Main Results:
- Clindamycin-2-phosphate exhibits weak intrinsic antibacterial activity.
- In vivo, clindamycin-2-phosphate is metabolized to clindamycin, restoring potent activity.
- Both compounds show increased antibacterial activity in alkaline conditions.
- Antibacterial activity is largely independent of inoculum size.
- Clindamycin-2-phosphate demonstrated comparable therapeutic effects to clindamycin in vivo despite lower in vitro activity.
Conclusions:
- Clindamycin-2-phosphate serves as an effective prodrug, delivering active clindamycin in vivo.
- The efficacy of clindamycin and its phosphate ester is pH-dependent, favoring alkaline environments.
- This injectable formulation offers a viable therapeutic option, particularly in conditions where clindamycin is indicated.